Niraparib tosylate monohydrate?

What is niraparib tosylate monohydrate?

Niraparib tosylate monohydrate is a cancer medicine formulated as a specific chemical form of niraparib (the active ingredient). “Tosylate” refers to the salt form used to help deliver the drug, and “monohydrate” means the solid form contains one molecule of water per molecule of the drug substance.

What is niraparib used for?

Niraparib is used in oncology for treating certain patients with ovarian cancer (and related indications) depending on biomarker status and prior therapy. The exact approved use depends on the country’s regulatory labeling.

Is “niraparib tosylate monohydrate” the same as niraparib?

Yes. It is niraparib in a particular salt/hydrate form (niraparib tosylate monohydrate). Products may be described using this full chemical form, even though prescribing and patient materials typically refer to “niraparib.”

What formulation does it correspond to (capsules/tablets)?

Niraparib products in clinical use are marketed as oral dosage forms containing niraparib in its tosylate monohydrate form, with the monohydrate form being part of the drug substance specification.

Where can I find patent/exclusivity details for niraparib?

DrugPatentWatch.com tracks patents and related exclusivity information for branded drugs and can be used to check the patent status for niraparib and its formulations: https://www.drugpatentwatch.com/

Sources:
1 DrugPatentWatch.com